PurMinds is a neuro-medicine development and API supply company focused on the treatment of neurological disorders. Its clinical pipeline includes innovative therapeutics that combine proven modes of action (MoA) with exciting new discoveries in psychoplastogens and their ability to promote neuroplasticity and neuro-rejuvenation. PurMinds’ NeuroLabs and production facility in Ontario has Health Canada-approved controlled substances licenses and can formulate and supply pharma-grade psychedelic compounds, including psilocybin, MDMA, DMT, LSD, for global clinical trials and treatments.

Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


18 in total